|
Welcome to our PK/PD (Pharmacokinetics/Pharmacodynamics) Services page, where we offer a comprehensive range of services to support translational research and clinical needs. Our expertise in PK/PD enables us to provide valuable insights into drug efficacy, dosing regimens, and treatment optimisation.
Preclinical HFIM PK/PD Experiments:
we specialize in conducting preclinical pharmacokinetic/pharmacodynamic experiments using the Hollow-Fibre Infection Model (HFIM). This dynamic model allows for a deeper understanding of drug activity by simulating in vivo conditions within the laboratory setting. With the HFIM, we can perform dose-ranging studies to determine optimal drug concentrations and assess the effectiveness of antimicrobial agents at clinical concentrations. Furthermore, we conduct synergy testing to evaluate the combined effects of multiple drugs. Additionally, our HFIM experiments provide critical insights into treatment duration, helping to determine the optimal duration of therapy required for successful outcomes.
Antimicrobial PK/PD Modeling:
our team possesses extensive experience in antimicrobial PK/PD modeling, which involves the analysis and interpretation of preclinical and clinical data. Through advanced mathematical modeling techniques, we can characterize the relationship between drug exposure, microbial response, and clinical outcomes. This modeling approach allows for a deeper understanding of drug pharmacokinetics and pharmacodynamics, aiding in the optimization of dosing regimens and treatment strategies. By leveraging PK/PD modeling, we can enhance decision-making in the development of antimicrobial agents.
Pre-Clinical Drug Discovery/Support:
our translational PK/PD services extend to pre-clinical drug discovery, offering valuable support in the early stages of antimicrobial agent development. We collaborate with researchers and pharmaceutical companies to design and implement PK/PD studies that assess the pharmacokinetics, pharmacodynamics, and efficacy of novel drug candidates. By leveraging our expertise, you can gain critical insights into the potential of your compounds, optimize their therapeutic potential, and make informed decisions during the drug discovery process.
Support for Clinical Trials:
we provide support for clinical trials that require PK/PD expertise. Our team can assist in the design and implementation of studies involving dose optimization, treatment duration assessment, and synergy testing. We work closely with researchers, clinicians, and pharmaceutical companies to develop tailored PK/PD strategies for clinical trials. With our support, you can make informed decisions about dosing, treatment regimens, and the evaluation of therapeutic outcomes.
At APPL, our PK/PD services are backed by a team of skilled scientists who possess deep knowledge in the field of antimicrobial pharmacokinetics and pharmacodynamics. We utilize state-of-the-art analytical techniques and advanced mathematical modeling approaches to deliver accurate and insightful results.
Contact us today to discuss how our PK/PD services can benefit your research, drug development, or clinical trials. Together, we can optimize treatment strategies, enhance therapeutic outcomes, and contribute to the fight against antimicrobial resistance..
| 
